Drug Shortage Report for PARSITAN 50
| Report ID | 71845 |
| Drug Identification Number | 01927744 |
| Brand name | PARSITAN 50MG |
| Common or Proper name | PARSITAN |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ETHOPROPAZINE |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N04AA |
| ATC description | ANTICHOLINERGIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-01-08 |
| Actual start date | 2019-01-09 |
| Estimated end date | 2019-01-23 |
| Actual end date | 2019-01-25 |
| Shortage status | Resolved |
| Updated date | 2019-02-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-01-10 | English | Compare |
| v2 | 2019-01-10 | English | Compare |
| v3 | 2019-01-10 | French | Compare |
| v4 | 2019-02-06 | English | Compare |
| v5 | 2019-02-06 | French | Compare |
Showing 1 to 5 of 5